1. Home
  2. PCLA vs XLO Comparison

PCLA vs XLO Comparison

Compare PCLA & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCLA
  • XLO
  • Stock Information
  • Founded
  • PCLA 2008
  • XLO 2016
  • Country
  • PCLA Japan
  • XLO United States
  • Employees
  • PCLA N/A
  • XLO N/A
  • Industry
  • PCLA Building Products
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCLA Consumer Discretionary
  • XLO Health Care
  • Exchange
  • PCLA Nasdaq
  • XLO Nasdaq
  • Market Cap
  • PCLA 32.3M
  • XLO 37.9M
  • IPO Year
  • PCLA 2025
  • XLO 2021
  • Fundamental
  • Price
  • PCLA $0.55
  • XLO $0.75
  • Analyst Decision
  • PCLA
  • XLO Buy
  • Analyst Count
  • PCLA 0
  • XLO 1
  • Target Price
  • PCLA N/A
  • XLO $4.00
  • AVG Volume (30 Days)
  • PCLA 119.3K
  • XLO 233.4K
  • Earning Date
  • PCLA 01-01-0001
  • XLO 05-13-2025
  • Dividend Yield
  • PCLA N/A
  • XLO N/A
  • EPS Growth
  • PCLA N/A
  • XLO N/A
  • EPS
  • PCLA N/A
  • XLO N/A
  • Revenue
  • PCLA $5,475,228.00
  • XLO $6,344,000.00
  • Revenue This Year
  • PCLA N/A
  • XLO $668.96
  • Revenue Next Year
  • PCLA N/A
  • XLO $14.49
  • P/E Ratio
  • PCLA N/A
  • XLO N/A
  • Revenue Growth
  • PCLA 40.19
  • XLO N/A
  • 52 Week Low
  • PCLA $0.46
  • XLO $0.62
  • 52 Week High
  • PCLA $9.80
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • PCLA N/A
  • XLO 50.44
  • Support Level
  • PCLA N/A
  • XLO $0.63
  • Resistance Level
  • PCLA N/A
  • XLO $0.80
  • Average True Range (ATR)
  • PCLA 0.00
  • XLO 0.06
  • MACD
  • PCLA 0.00
  • XLO 0.01
  • Stochastic Oscillator
  • PCLA 0.00
  • XLO 72.93

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: